Form D · Biotechnology
TODOS MEDICAL LTD.
Rehovot, L3 · CIK 0001645260
Offering snapshot reported Jun 13, 2019 · SEC filing
- Reported sold
- $1.45M Indefinite offering
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 14, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 13, 2019 | Initial | $1,452,500 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $105K
- Form D file number
- 021-341841
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Alternative Execution Group | 2329313 |
Source: Form D, filed Jun 13, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Moshe Abramovitz | Director |
| David Ben Naim | Executive |
| Colin Bier | Director |
| Ronit Even Zahav Meitin | Director |
| Alon Ostovitzky | Director |
| Moshe Schlisser | Director |
| Alon Shalev | Director |
| Herman Weiss | Director, Executive |
| Udi Zelig | Executive |
| Rami Zigdon | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Hamada Street
Rehovot, L3, 7670301
Rehovot, L3, 7670301